ES420241A1 - Phthalazine derivatives and their use in pharmaceutical compo sitions - Google Patents
Phthalazine derivatives and their use in pharmaceutical compo sitionsInfo
- Publication number
- ES420241A1 ES420241A1 ES420241A ES420241A ES420241A1 ES 420241 A1 ES420241 A1 ES 420241A1 ES 420241 A ES420241 A ES 420241A ES 420241 A ES420241 A ES 420241A ES 420241 A1 ES420241 A1 ES 420241A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- give
- compound
- formula
- cooh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
A procedure for preparing phthalazine derivatives of formula I ** (See formula) ** or its enolic or entholic forms of formula Ia ** (See formula) ** where Q is COOH, COOR6, where R6 is an ester forming group or CH2OH; X is oxygen or sulfur; Z is hydrogen or acyl; R is hydrogen or alcohol, and Ar is an unsubstituted phenyl group at the ortho positions and may have one or more substituents, or with which a substituted or unsubstituted mono- or polycyclic ring is fused, which ring or rings may contain one or more heteroatoms, provided that (i) when Q is COOH, COOMe or COOEt, X is oxygen, and R is hydrogen or methyl, then Ar is not phenyl, m or p-chlorophenyl, m or p-nitrophenyl, p - (p-nitrophenylazo) phenyl or p-phenylazophenyl, or (ii) when Q is COOH, X is oxygen and R is hydrogen then Ar is not m or p-aniline or p-acetamidophenyl, or a pharmaceutically acceptable salt with a base inorganic or organic of any compound that is acidic, characterized in that a compound of formula VI ** (See formula) ** wherein Ar1 is Ar or Ar bearing an iodine, bromine, or chlorine substituent in the ortho position, treated with an aqueous or alcoholic acid to hydrolyze the SO3- group to give a hydroxy group; and in the case that Ar1 has an iodine, bromine or chlorine atom in the ortho position, the compound is hydrogenated to remove this halogen group, and if desired a) when Ar1 is meta- or para-nitrophenyl, the nitro group (i) by reductive alcoholization to give an N, N-dialkoxylamino group or (ii) reducing it to an amino group which can itself be further modified later, if desired, by alcoholization to give an N-alcoholic- or N group, N-dialcohilamino; or treatment with a sulfonyl halide to give a sulfonamido group, optionally followed by alkylation to give an N-substituted alcoholic sulfonamido group; either reductive alcoholization or aralkoxylation to give an N-monoalkoxylamino, N, N-dialcohilamino or N-aralcohilo group, or diazotization followed by treatment with an alkanol to give an alkoxy group; either diazotization followed by reduction to give a hydrazino group, or acylation followed by alkylation to give an N-alcoholylacylamino group, or reaction with 2,5-dimethoxytetrahydrofuran to give a 1-pyrrolyl group; b) if desired, a compound obtained is alcoholized to give a compound in which R is alcoholic; c) if desired, a compound obtained is esterified to give a compound in which Q is an ester group; d) if desired, COOH is converted to CH2OH; e) if desired, a compound obtained is sulfided to give a compound in which X is sulfur; f) if desired, a compound obtained is acylated to give a compound in which Z is acyl; and g) if desired, a pharmaceutically acceptable salt is formed with an inorganic or organic base of any compound that is an acid. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5097372A GB1398549A (en) | 1972-11-06 | 1972-11-06 | Phthalazine derivatives and their use in pharmaceutical compo sitions |
Publications (1)
Publication Number | Publication Date |
---|---|
ES420241A1 true ES420241A1 (en) | 1977-01-01 |
Family
ID=10458145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES420241A Expired ES420241A1 (en) | 1972-11-06 | 1973-11-03 | Phthalazine derivatives and their use in pharmaceutical compo sitions |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS49132092A (en) |
AT (1) | AT334906B (en) |
BE (1) | BE806922A (en) |
BG (1) | BG24953A3 (en) |
CA (1) | CA1032162A (en) |
CH (1) | CH601255A5 (en) |
DD (1) | DD110270A5 (en) |
DE (1) | DE2355394A1 (en) |
ES (1) | ES420241A1 (en) |
GB (1) | GB1398549A (en) |
HU (1) | HU170941B (en) |
IE (1) | IE39444B1 (en) |
IL (1) | IL43546A (en) |
LU (1) | LU68746A1 (en) |
NL (1) | NL7315129A (en) |
NO (1) | NO139222C (en) |
PL (1) | PL100831B1 (en) |
RO (1) | RO63009A (en) |
SE (1) | SE403375B (en) |
ZA (1) | ZA738456B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
-
1972
- 1972-11-06 GB GB5097372A patent/GB1398549A/en not_active Expired
-
1973
- 1973-11-01 IE IE1983/73A patent/IE39444B1/en unknown
- 1973-11-02 IL IL7343546A patent/IL43546A/en unknown
- 1973-11-02 ZA ZA738456A patent/ZA738456B/en unknown
- 1973-11-03 ES ES420241A patent/ES420241A1/en not_active Expired
- 1973-11-05 NL NL7315129A patent/NL7315129A/xx not_active Application Discontinuation
- 1973-11-05 SE SE7315013A patent/SE403375B/en unknown
- 1973-11-05 DD DD174466A patent/DD110270A5/xx unknown
- 1973-11-05 HU HU73BO00001470A patent/HU170941B/en unknown
- 1973-11-05 AT AT928273A patent/AT334906B/en not_active IP Right Cessation
- 1973-11-05 NO NO734248A patent/NO139222C/en unknown
- 1973-11-05 LU LU68746A patent/LU68746A1/xx unknown
- 1973-11-05 BE BE137413A patent/BE806922A/en unknown
- 1973-11-06 PL PL1973166347A patent/PL100831B1/en unknown
- 1973-11-06 DE DE19732355394 patent/DE2355394A1/en active Pending
- 1973-11-06 CA CA185,148A patent/CA1032162A/en not_active Expired
- 1973-11-06 JP JP48124862A patent/JPS49132092A/ja active Pending
- 1973-11-06 CH CH1558373A patent/CH601255A5/xx not_active IP Right Cessation
- 1973-11-06 RO RO7300076548A patent/RO63009A/en unknown
- 1973-11-25 BG BG7300024937A patent/BG24953A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA1032162A (en) | 1978-05-30 |
RO63009A (en) | 1978-05-15 |
BG24953A3 (en) | 1978-06-15 |
IE39444L (en) | 1974-05-06 |
PL100831B1 (en) | 1978-11-30 |
LU68746A1 (en) | 1974-11-21 |
SE403375B (en) | 1978-08-14 |
GB1398549A (en) | 1975-06-25 |
BE806922A (en) | 1974-05-06 |
IL43546A (en) | 1976-11-30 |
NO139222C (en) | 1979-01-24 |
IE39444B1 (en) | 1978-10-11 |
ZA738456B (en) | 1974-09-25 |
JPS49132092A (en) | 1974-12-18 |
DE2355394A1 (en) | 1974-05-16 |
CH601255A5 (en) | 1978-06-30 |
NL7315129A (en) | 1974-05-08 |
AU6212773A (en) | 1975-05-08 |
IL43546A0 (en) | 1974-03-14 |
NO139222B (en) | 1978-10-16 |
HU170941B (en) | 1977-10-28 |
DD110270A5 (en) | 1974-12-12 |
ATA928273A (en) | 1976-06-15 |
AT334906B (en) | 1977-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES378765A1 (en) | 3 7-(ring-substituted) cephalosporin compounds | |
ES413639A1 (en) | Dopamine derivatives | |
SE7500871L (en) | PROCEDURE FOR THE PREPARATION OF 3-METHYLENCE PHALOSPORT ASSOCIATIONS | |
ES424483A1 (en) | Hererocyclic derivatives of a guanidine | |
ES420241A1 (en) | Phthalazine derivatives and their use in pharmaceutical compo sitions | |
ES390163A1 (en) | Procedure for the preparation of amino-derivatives of pirazolo (3,4-b) pyridine-5-carboxylic acids. (Machine-translation by Google Translate, not legally binding) | |
ES288794A1 (en) | Procedure for obtaining new 1,2,3-triazolic fluorescent derivatives of 3-phenyl-cumarine (Machine-translation by Google Translate, not legally binding) | |
ES426427A1 (en) | Pharmaceutical compositions comprising nitrocarbostyrils for the treatment of allergic and immunological hypersensitivity | |
ES405479A1 (en) | Benzodiazepin-2-ones | |
GB986210A (en) | Cephalosporin compounds | |
ES404744A1 (en) | Cephalosporin derivatives | |
ES432450A1 (en) | Procedure for preparing tiazol derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES412068A1 (en) | Xylidides | |
ES426948A1 (en) | Procedure for the preparation of new 1,4-benzodiazepinas. (Machine-translation by Google Translate, not legally binding) | |
ES446132A1 (en) | A procedure for the preparation of new derivatives of 2-alkyl (bottom) -2 or 3-cefem-4-carboxylic acid. (Machine-translation by Google Translate, not legally binding) | |
ES418051A1 (en) | Phthalimido derivatives | |
ES406131A1 (en) | Procedure for the preparation of acids 4- (4-bifenilil) - butirrics and their steres. (Machine-translation by Google Translate, not legally binding) | |
FR2073286A1 (en) | Substd anilines - with antirheumatic analgesic and antiinflammatory activity | |
ES428897A1 (en) | N-hydroxy-amidine compounds | |
ES460141A1 (en) | A procedure for the production of acid derivatives 7alfa-metoxy-7beta-heterociclo-tioncetamido-3-heterociclo-tiotiometil-delta3-cefem-4-carboxilico. (Machine-translation by Google Translate, not legally binding) | |
ES385834A1 (en) | [NOVEL] ESTERS OF alpha-CARBOXYBENZYLPENCILLIN | |
ES418038A1 (en) | 2,6-methano-3-benzazocines and preparation thereof | |
ES334733A1 (en) | Procedure for preparing derivatives of acid esters-5halobenzoicos. (Machine-translation by Google Translate, not legally binding) | |
GB1480231A (en) | Benzalicyclic carboxylic acid derivatives | |
ES397770A1 (en) | N-alkenyltetracycline derivatives |